Sarepta Therapeutics, Inc.
CHIMERIC PEPTIDES FOR ANTISENSE DELIVER
Last updated:
Abstract:
Provided herein are oligonucleotides, chimeric peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject oligonucleotides, chimeric peptides, and peptide-oligonucleotide-conjugates described herein.
Status:
Application
Type:
Utility
Filling date:
15 Mar 2019
Issue date:
26 Aug 2021